Hi

Looking for reliable pharma & medical sourcing?

REQUEST QUOTE

Rely on 70+ years of group manufacturing strength, international certified products and full-chain after-service. Submit inquiry now.

SUBMIT NOW

Golden Gate Pharma

Key words:

Products News

Metronidazole Infusion Western Medicine


Potent Anaerobicidal Nitro -imidazole derivative. The exact mechanism of action of metronidazole is unknown. At physiologic pH, metronidazole is un-ionized and taken up readily by anaerobic organisms.

5% Glucose Infusion Nutrition Medicine


Used for supplement of energy and body liquid; used for the scarcity of feeding and body liquid caused by all cases (such as vomiting, diarrhea), intravenous hyperalimentation,ketosis;

Ringer Lactate Infusion Medicine


It is indicated to adjust the equilibrium of humour electrolyte acid and alkali, used for metabolic acid toxicosis or dehydration caused by metabolic acid toxicosis.

Ciprofloxacin Lactate Infusion Anti-Infection Drug


Broad spectrum aerobicidal quinolone antibiotic. In vitro ciprofloxacin lactate can resist all of the G- Bacteria effectively. It also has effect on the resistance of G+ Bacteria.

Two New Drug Varieties (Three Specifications) of SSY Group Obtain Approval


On June 22, two new pharmaceutical varieties with three specifications independently developed by SSY Group obtained production registration approvals issued by the National Medical Products Administration (NMPA), and were deemed to have passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs.

SSY Group Shines at CPHI China 2026 – the 24th World Pharmaceutical Raw Materials Exhibition


Gathering global pharmaceutical strengths to jointly unlock new industrial growth opportunities. Held from June 16 to 18 at Shanghai New International Expo Centre, CPHI China 2026 (the 24th World Pharmaceutical Raw Materials Exhibition) welcomed a grand opening.

Cefpodoxime Proxetil Dry Suspension (50mg) of SSY Group Granted Approval


On June 15, the Class 3 chemical drug Cefpodoxime Proxetil Dry Suspension (50mg) independently developed by SSY Group obtained the production registration approval issued by the National Medical Products Administration (NMPA)

SSY Group Debuts at 2026 South Africa International Food & Food Processing Exhibition


Local time June 10, the 2026 South Africa International Food & Food Processing Exhibition grandly opened at Cape Town International Convention Centre. The international trade team of SSY Group attended the show with bulk and specialty raw material products to actively explore the African market.

SSY Group Obtains Registration Approvals for Ceftizoxime Sodium for Injection (1.0g & 0.5g)


On June 8, SSY Group obtained registration approval documents for two specifications of Ceftizoxime Sodium for Injection (1.0g and 0.5g). Since the start of this year, the Group has secured 44 new product approvals, including 33 for finished preparations and 11 for APIs.

Shijiazhuang No.4 Pharmaceutical Boosts Development of Modified Innovative Drugs


Per the agreement, the two parties will jointly develop a Class 2.2 antispasmodic medicine for children and a Class 2.3 therapeutic drug for chronic obstructive pulmonary disease (COPD). Both are modified new chemical drugs designed to address unmet clinical medical demands.